| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |